Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

NCT04547127 ·Status: COMPLETED ·Phase: PHASE2

Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

NCT04634799 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

NCT04523181 ·Status: COMPLETED ·Phase: PHASE2

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

NCT05799495 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19

NCT05365321 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

NCT05033145 ·Status: COMPLETED ·Phase: PHASE3

Tafenoquine in Patients With Mild to Moderate COVID-19

NCT04533347 ·Status: COMPLETED ·Phase: PHASE2

Long-term Effects of COVID-19

NCT05220514 ·Status: COMPLETED

Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients

NCT04621123 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

NCT05897541 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

NCT04547140 ·Status: TERMINATED ·Phase: PHASE2

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

NCT06349655 ·Status: COMPLETED

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

NCT04405999 ·Status: COMPLETED ·Phase: PHASE4

COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

NCT04884477 ·Status: COMPLETED

Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19

NCT04532931 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort

NCT04345991 ·Status: COMPLETED ·Phase: PHASE2

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

NCT07156864 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

NCT04554992 ·Status: COMPLETED ·Phase: PHASE1

Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.

NCT03212716 ·Status: TERMINATED ·Phase: PHASE2

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

NCT05947812 ·Status: UNKNOWN ·Phase: PHASE2

Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19

NCT04549922 ·Status: COMPLETED ·Phase: PHASE2

AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19

NCT04507256 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People

NCT05580003 ·Status: COMPLETED ·Phase: PHASE1